DOE PAGES title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Structural Characterization of TRAF6 N-Terminal for Therapeutic Uses and Computational Studies on New Derivatives

Journal Article · · Pharmaceuticals
DOI: https://doi.org/10.3390/ph16111608 · OSTI ID:2327002
 [1]; ORCiD logo [2]; ORCiD logo [3]; ORCiD logo [4]; ORCiD logo [5];  [5]; ORCiD logo [5];  [6];  [6];  [7]; ORCiD logo [8];  [9]; ORCiD logo [5]; ORCiD logo [10]; ORCiD logo [11]
  1. Koç University, Istanbul (Turkey); SLAC
  2. Kumamoto University (Japan); Anadolu University, Eskisehir (Turkey)
  3. European University of Lefke, Northern Cyprus, Mersin (Turkey)
  4. Biruni University, Istanbul (Turkey)
  5. Kumamoto University (Japan)
  6. Izmir Katip Celebi University, Izmir (Turkey)
  7. Izmir Katip Celebi University, Izmir (Turkey); Hacettepe University, Ankara (Turkey)
  8. University of Tokyo (Japan)
  9. Kumamoto University (Japan); Science Farm Ltd., Kumamoto (Japan)
  10. Koç University, Istanbul (Turkey); Kumamoto University (Japan); Science Farm Ltd., Kumamoto (Japan)
  11. Koç University, Istanbul (Turkey); SLAC National Accelerator Laboratory (SLAC), Menlo Park, CA (United States)

Tumor necrosis factor receptor-associated factors (TRAFs) are a protein family with a wide variety of roles and binding partners. Among them, TRAF6, a ubiquitin ligase, possesses unique receptor binding specificity and shows diverse functions in immune system regulation, cellular signaling, central nervous system, and tumor formation. TRAF6 consists of an N-terminal Really Interesting New Gene (RING) domain, multiple zinc fingers, and a C-terminal TRAF domain. TRAF6 is an important therapeutic target for various disorders and structural studies of this protein are crucial for the development of next-generation therapeutics. Here, we presented a TRAF6 N-terminal structure determined at the Turkish light source “Turkish DeLight” to be 3.2 Å resolution at cryogenic temperature (PDB ID: 8HZ2). This structure offers insight into the domain organization and zinc-binding, which are critical for protein function. Since the RING domain and the zinc fingers are key targets for TRAF6 therapeutics, structural insights are crucial for future research. Separately, we rationally designed numerous new compounds and performed molecular docking studies using this template (PDB ID:8HZ2). According to the results, 10 new compounds formed key interactions with essential residues and zinc ion in the N-terminal region of TRAF6. Molecular dynamic (MD) simulations were performed for 300 ns to evaluate the stability of three docked complexes (compounds 256, 322, and 489). Compounds 256 and 489 was found to possess favorable bindings with TRAF6. These new compounds also showed moderate to good pharmacokinetic profiles, making them potential future drug candidates as TRAF6 inhibitors.

Research Organization:
SLAC National Accelerator Laboratory (SLAC), Menlo Park, CA (United States)
Sponsoring Organization:
USDOE Office of Science (SC); TÜBİTAK 1001
Grant/Contract Number:
AC02-76SF00515
OSTI ID:
2327002
Journal Information:
Pharmaceuticals, Journal Name: Pharmaceuticals Journal Issue: 11 Vol. 16; ISSN 1424-8247
Publisher:
MDPICopyright Statement
Country of Publication:
United States
Language:
English

References (58)

A New Inhibitor of ADAM17 Composed of a Zinc-Binding Dithiol Moiety and a Specificity Pocket-Binding Appendage journal November 2021
Tumor Necrosis Factor Receptor-associated Factor 6 Is an Intranuclear Transcriptional Coactivator in Osteoclasts journal November 2008
Identification of a new TRAF6 inhibitor for the treatment of hepatocellular carcinoma journal July 2021
PHENIX: a comprehensive Python-based system for macromolecular structure solution journal January 2010
TRAF Molecules in Inflammation and Inflammatory Diseases journal December 2017
Rapid and efficient ambient temperature X-ray crystal structure determination at Turkish Light Source journal May 2023
The activity of TRAF RING homo- and heterodimers is regulated by zinc finger 1 journal November 2017
Structural classification of zinc fingers: SURVEY AND SUMMARY journal January 2003
Signaling to NF-κB journal September 2004
Resveratrol induces depletion of TRAF6 and suppresses prostate cancer cell proliferation and migration journal January 2020
Phaser crystallographic software journal July 2007
A model for the tertiary structure of the 28 residue DNA-binding motif (‘zinc finger’) common to many eukaryotic transcriptional regulatory proteins journal January 1988
TNF receptor–associated factor 6 interacts with ALS-linked misfolded superoxide dismutase 1 and promotes aggregation journal March 2020
Role of the NF-κB signaling pathway in the pathogenesis of colorectal cancer journal February 2020
TRAF6 Contributes to CFA-Induced Spinal Microglial Activation and Chronic Inflammatory Pain in Mice journal March 2021
Zinc Finger Proteins in Neuro-Related Diseases Progression journal November 2021
Novel beta-lactam substituted benzenesulfonamides: in vitro enzyme inhibition, cytotoxic activity and in silico interactions journal August 2023
The relationship between TRAF6 and tumors journal September 2020
A novel inhibitor of farnesyltransferase with a zinc site recognition moiety and a farnesyl group journal August 2017
A general purpose model for the condensed phases of water: TIP4P/2005 journal December 2005
Expression of TRAF6 in peripheral blood B cells of patients with myasthenia gravis journal August 2022
Zinc-finger proteins in health and disease journal November 2017
Coot model-building tools for molecular graphics journal November 2004
The RING Domain and First Zinc Finger of TRAF6 Coordinate Signaling by Interleukin-1, Lipopolysaccharide, and RANKL journal September 2008
The NF-κB activation pathways, emerging molecular targets for cancer prevention and therapy journal December 2009
Roles of NF-κB in Cancer and Inflammatory Diseases and Their Therapeutic Approaches journal March 2016
Metal-Chelating Inhibitors of a Zinc Finger Protein HIV-EP1. Remarkable Potentiation of Inhibitory Activity by Introduction of SH Groups journal January 1996
Roles of TRAF6 in Central Nervous System journal October 2018
Cryocooling and radiation damage in macromolecular crystallography journal December 2005
Litopenaeus vannamei tumor necrosis factor receptor-associated factor 6 (TRAF6) responds to Vibrio alginolyticus and white spot syndrome virus (WSSV) infection and activates antimicrobial peptide genes journal January 2011
Pathogenic Functions of Tumor Necrosis Factor Receptor-Associated Factor 6 Signaling Following Traumatic Brain Injury journal April 2021
USP2a negatively regulates IL-1β- and virus-induced NF-κB activation by deubiquitinating TRAF6 journal May 2012
Novel Findings in Teleost TRAF4, a Protein Acts as an Enhancer in TRIF and TRAF6 Mediated Antiviral and Inflammatory Signaling journal July 2022
Novel Zinc Chelators with Dual Activity in the Inhibition of the .kappa.B Site-Binding Proteins, HIV-EP1 and NF-.kappa.B journal August 1995
Inhibition of TRAF6 ubiquitin-ligase activity by PRDX1 leads to inhibition of NFKB activation and autophagy activation journal July 2018
A Dithiol Compound Binds to the Zinc Finger Protein TRAF6 and Suppresses Its Ubiquitination journal October 2017
The E3 Ubiquitin Ligase TRAF6 Interacts with the Cellular Prion Protein and Modulates Its Solubility and Recruitment to Cytoplasmic p62/SQSTM1-Positive Aggresome-Like Structures journal January 2022
Identification of New L-Heptanoylphosphatidyl Inositol Pentakisphosphate Derivatives Targeting the Interaction with HIV-1 Gag by Molecular Modelling Studies journal October 2022
E2 interaction and dimerization in the crystal structure of TRAF6 journal May 2009
Zinc finger proteins: new insights into structural and functional diversity journal February 2001
TNF receptor-associated factor 6 (TRAF6) plays crucial roles in multiple biological systems through polyubiquitination-mediated NF-κB activation journal April 2021
TRAF6 regulates the signaling pathway influencing colorectal cancer function through ubiquitination mechanisms journal March 2022
TRIM37 negatively regulates inflammatory responses induced by virus infection via controlling TRAF6 ubiquitination journal June 2021
Novel coumarin-chalcone derivatives: Synthesis, characterization, antioxidant, cyclic voltammetry, molecular modelling and biological evaluation studies as acetylcholinesterase, α-glycosidase, and carbonic anhydrase inhibitors journal September 2023
Tumor Necrosis Factor Receptor Associated Factor 6 (TRAF6) N-terminal Domain other January 2023
Tumor necrosis factor receptor-associated factors (TRAFs) journal October 2001
Tumor Necrosis Factor Receptor-Associated Factor (TRAF) Family: Adapter Proteins That Mediate Cytokine Signaling journal January 2000
Protocol for structure determination of SARS-CoV-2 main protease at near-physiological-temperature by serial femtosecond crystallography journal March 2022
Minimum structural requirements for inhibitors of the zinc finger protein TRAF6 journal August 2019
Cinchonine induces apoptosis of HeLa and A549 cells through targeting TRAF6 journal February 2017
Synthetic inhibitors of regulatory proteins involved in the signaling pathway of the replication of human immunodeficiency virus 1 journal January 1997
The RING finger protein family in health and disease journal August 2022
Cryogenic X-ray crystallographic studies of biomacromolecules at Turkish Light Source "Turkish DeLight" journal January 2023
SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules journal March 2017
Tumor necrosis factor receptor‐ associated factor 6 (TRAF6) regulation of development, function, and homeostasis of the immune system journal June 2015
Benzoyl‑xanthone derivative induces apoptosis in MCF‑7 cells by binding TRAF6 journal December 2021
Computer-aided drug design journal March 2023
Zinc finger proteins in cancer progression journal July 2016